Abstract
Background
ZFAS1 is a newly identified long noncoding RNA (lncRNA) that promotes tumor growth and metastasis. Exosomes mediate cellular communications in cancer by transmitting active molecules. The presence of ZFAS1 in the circulating exosomes and the roles of exosomal ZFAS1 in gastric cancer (GC) remains unknown. The aim of this study was to investigate the potential roles of exosomal ZFAS1 in GC.
Methods
The expression of ZFAS1 was examined in the tumor tissues, serum samples, serum exosomes of GC patients and cell lines using qRT-PCR. The correlation between ZFAS1 expression and the clinicopathological characteristics was analyzed. The characteristics of exosomes were identified using transmission electron microscope (TEM), Nanoparticle Tracking Analysis (NTA), and western blot. The biological roles of ZFAS1 in GC cell growth and mobility were investigated using cell counting, cell colony formation, and transwell migration assay. The potential mechanism of ZFAS1 was demonstrated using flow cytometry, western blot, and qRT-PCR.
Results
ZFAS1 expression was elevated in GC cells, tumor tissues, serum and serum exosomes of GC patients. The increased ZFAS1 expression was significantly correlated with lymphatic metastasis and TNM stage. ZFAS1 knockdown inhibited the proliferation and migration of GC cells by suppressing cell cycle progression, inducing apoptosis, and inhibiting epithelial-mesenchymal transition (EMT). On the contrary, ZFAS1 overexpression promoted the proliferation and migration of GC cells. Moreover, ZFAS1 was present in exosomes and could be transmitted by exosomes to enhance GC cell proliferation and migration.
Conclusion
ZFAS1 could be delivered by exosomes to promote GC progression, which suggests that ZFAS1 may serve as a potential diagnostic and prognostic biomarker for GC.
Similar content being viewed by others
References
Askarian-Amiri ME et al (2011) SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer. RNA 17:878–891. doi:10.1261/rna.2528811
Chen W et al (2016) Cancer statistics in China, 2015. CA Cancer J Clin 66:115–132. doi:10.3322/caac.21338
Chun HW, Hong R (2016) Significance of the hedgehog pathway-associated proteins Gli-1 and Gli-2 and the epithelial-mesenchymal transition-associated proteins Twist and E-cadherin in hepatocellular carcinoma. Oncol Lett 12:1753–1762 doi:10.3892/ol.2016.4884
Dong L et al (2016) Circulating long RNAs in serum extracellular vesicles: Their characterization and potential application as biomarkers for diagnosis of colorectal cancer. Cancer Epidemiol Biomarkers Prev 25:1158–1166. doi:10.1158/1055-9965.EPI-16-0006
Ferlay J et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386. doi:10.1002/ijc.29210
Isin M et al (2015) Exosomal lncRNA-p21 levels may help to distinguish prostate cancer from benign disease. Front Genet 6:168 doi:10.3389/fgene.2015.00168
Karlsson O, Rodosthenous RS, Jara C, Brennan KJ, Wright RO, Baccarelli AA, Wright RJ (2016) Detection of long non-coding RNAs in human breastmilk extracellular vesicles: Implications for early child development Epigenetics:0 doi:10.1080/15592294.2016.1216285
Li Q et al (2015a) Plasma long noncoding RNA protected by exosomes as a potential stable biomarker for gastric cancer. Tumour Biol 36:2007–2012. doi:10.1007/s13277-014-2807-y
Li T et al (2015b) Amplification of long noncoding RNA ZFAS1 promotes metastasis in hepatocellular carcinoma. Cancer Res 75:3181–3191. doi:10.1158/0008-5472.CAN-14-3721
Li T, Mo X, Fu L, Xiao B, Guo J (2016) Molecular mechanisms of long noncoding RNAs on gastric cancer. Oncotarget 7:8601–8612. doi:10.18632/oncotarget.6926
Liu H, Lv Z, Guo E (2015) Knockdown of long noncoding RNA SPRY4-IT1 suppresses glioma cell proliferation, metastasis and epithelial-mesenchymal transition. Int J Clin Exp Pathol 8:9140–9146
Lu M, Liu Z, Li B, Wang G, Li D, Zhu Y (2016) The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway. J Cancer Res Clin Oncol. doi:10.1007/s00432-016-2252-y
Ma P, Xu T, Huang M, Shu Y (2016) Increased expression of LncRNA PANDAR predicts a poor prognosis in gastric cancer. Biomed Pharmacother 78:172–176. doi:10.1016/j.biopha.2016.01.025
Nie F et al (2016) Long noncoding RNA ZFAS1 promotes gastric cancer cells proliferation by epigenetically repressing KLF2 and NKD2 expression. Oncotarget. doi:10.18632/oncotarget.9611
Qu L et al (2016) Exosome-transmitted lncARSR promotes Sunitinib resistance in renal cancer by acting as a competing endogenous RNA. Cancer Cell 29:653–668. doi:10.1016/j.ccell.2016.03.004
Riquelme I, Ili C, Roa JC, Brebi P (2016) Long non-coding RNAs in gastric cancer: mechanisms and potential applications. Oncotarget. doi:10.18632/oncotarget.9396
Sang Y et al (2016) LncRNA PANDAR regulates the G1/S transition of breast cancer cells by suppressing p16(INK4A) expression. Sci Rep 6:22366 doi:10.1038/srep22366
Shao Y et al (2016) LncRNA-RMRP promotes carcinogenesis by acting as a miR-206 sponge and is used as a novel biomarker for gastric cancer. Oncotarget. doi:10.18632/oncotarget.9336
Thorenoor N, Faltejskova-Vychytilova P, Hombach S, Mlcochova J, Kretz M, Svoboda M, Slaby O (2016) Long non-coding RNA ZFAS1 interacts with CDK1 and is involved in p53-dependent cell cycle control and apoptosis in colorectal cancer. Oncotarget 7:622–637. doi:10.18632/oncotarget.5807
Wang W, Xing C (2016) Upregulation of long noncoding RNA ZFAS1 predicts poor prognosis and prompts invasion and metastasis in colorectal cancer. Pathol Res Pract 212:690–695. doi:10.1016/j.prp.2016.05.003
Wu L et al (2016) Exosomes derived from gastric cancer cells activate NF-kappaB pathway in macrophages to promote cancer progression. Tumour Biol. doi:10.1007/s13277-016-5071-5
Yang H, Fu H, Xu W, Zhang X (2016) Exosomal non-coding RNAs: a promising cancer biomarker. Clin Chem Lab Med. doi:10.1515/cclm-2016-0029
Yu DD et al (2016) Exosomes from adriamycin-resistant breast cancer cells transmit drug resistance partly by delivering miR-222. Tumour Biol 37:3227–3235. doi:10.1007/s13277-015-4161-0
Zhan Y et al (2016) Up-regulation of long non-coding RNA PANDAR is associated with poor prognosis and promotes tumorigenesis in bladder cancer. J Exp Clin Cancer Res 35:83. doi:10.1186/s13046-016-0354-7
Zhang X, Yuan X, Shi H, Wu L, Qian H, Xu W (2015) Exosomes in cancer: small particle, big player. J Hematol Oncol 8:83. doi:10.1186/s13045-015-0181-x
Zhang Y et al (2016a) Reciprocal changes of circulating long non-coding RNAs ZFAS1 and CDR1AS predict acute myocardial infarction. Sci Rep 6:22384 doi:10.1038/srep22384
Zhang Z, Weaver DL, Olsen D, deKay J, Peng Z, Ashikaga T, Evans MF (2016b) Long non-coding RNA chromogenic in situ hybridisation signal pattern correlation with breast tumour pathology. J Clin Pathol 69:76–81. doi:10.1136/jclinpath-2015-203275
Zhao JH et al (2016) A novel long noncoding RNA-LOWEG is low expressed in gastric cancer and acts as a tumor suppressor by inhibiting cell invasion. J Cancer Res Clin Oncol 142:601–609. doi:10.1007/s00432-015-2071-6
Zheng H et al (2015) Epigenetically silenced long noncoding-SRHC promotes proliferation of hepatocellular carcinoma. J Cancer Res Clin Oncol 141:1195–1203. doi:10.1007/s00432-014-1871-4
Zhong S et al (2016) MicroRNA expression profiles of drug-resistance breast cancer cells and their exosomes. Oncotarget 7:19601–19609. doi:10.18632/oncotarget.7481
Zhou H et al (2016) Increased expression of long-noncoding RNA ZFAS1 is associated with epithelial mesenchymal transition of gastric cancer. Aging. doi:10.18632/aging.101048
Zhu S et al (2015) Reduced expression of the long non-coding RNA AI364715 in gastric cancer and its clinical significance. Tumour Biol 36:8041–8045. doi:10.1007/s13277-015-3543-7
Acknowledgements
This work was supported by the National Natural Science Foundation of China (81572075, 81201660), the Natural Science Foundation of the Jiangsu Province (BK20141303), Jiangsu Province for Outstanding Sci-tech Innovation Team in Colleges and Universities (SJK2013-10), Jiangsu Province’s Major Project in Research and Development (BE2015667), the Key Research and Development Project of Zhenjiang (SH2016044), and the Zhenjiang Science and Technology support program (FZ2014043).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Human and animal rights
All procedures performed in studies involving human participants were in accordance with the ethical standards of the Ethics Committee of Jiangsu University. This article does not contain any studies with animals performed by any of the authors.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
L. Pan and W. Liang have contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Pan, L., Liang, W., Fu, M. et al. Exosomes-mediated transfer of long noncoding RNA ZFAS1 promotes gastric cancer progression. J Cancer Res Clin Oncol 143, 991–1004 (2017). https://doi.org/10.1007/s00432-017-2361-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-017-2361-2